The QB1 of GLP
In this episode, our hosts are joined by the QB1 (or 4 of them) of GLP (Good Laboratory Practice), NAMSA’s Study Directors. Throughout this podcast, t...
BiocompCHATibility
Share:
Listens: 42
About
BiocompCHATibility Podcast, Presented by NAMSA Unforeseen challenges and roadblocks are often present when managing and conducting medical device biological safety programs. Join NAMSA for a first-of-its-type podcast series, “BiocompCHATibility,” as each episode features leading industry experts and discussion on how to proactively address specific medical device evaluation scenarios, regulatory expectations and new testing methodologies.
Biocomp and Beer
In its third year, the North American Biocompatibility Summit (NABS) is a limited-seating event that provides industry insights and expertise sharing ...
NAMSA Awarded ASCA Accreditation
NAMSA is pleased to announce that the U.S. Food and Drug Administration (FDA) granted the organization Accreditation Scheme for Conformity Assessment ...
Biocompatibility FAQ
Over the last year, the BiocompCHATibility Podcast hosts have been compiling questions asked by our listeners and training series attendees. In this e...
Why biocompatibility cares about preclinical: NAMSA and APS discuss
In this episode, our hosts are joined by APS’s Senior Director of Biocompatibility Services, Dr. Yan Chen, to discuss NAMSA’s acquisition of APS and t...
When to Go with In Vitro: Your Irritation Questions Answered
In this episode, our hosts answer listener questions regarding the new ISO 10993-23:2021 from NAMSA’s February 3, 2021 webinar. The standard recommend...
When to Go with In Vitro: Your Irritation Questions Answered
In this episode, our hosts answer listener questions regarding the new ISO 10993-23:2021 from NAMSA’s February 3, 2021 webinar. The standard recommend...
Is Your BioCompatibility Program Knocking Your Submission Off Track?
In this episode, our guests are joined by Syntactx’s Dr. Valerie Merkle, Associate Director – Regulatory Strategy, to discuss NAMSA’s recent acquisiti...
Is Your BioCompatibility Program Knocking Your Submission Off Track?
In this episode, our guests are joined by Syntactx’s Dr. Valerie Merkle, Associate Director – Regulatory Strategy, to discuss NAMSA’s recent acquisiti...
Oh No, Another Failed Cyto
In this episode, our guests are joined my NAMSA’s Melissa Cadaret to discuss the ever-confusing cytotoxicity failure. Manufacturers can have more que...